Fibroblast growth factor 21 attenuates salt-sensitive hypertension-induced nephropathy through anti-inflammation and anti-oxidation mechanism

BACKGROUND: Patients with salt-sensitive hypertension are often accompanied with severe renal damage and accelerate to end-stage renal disease, which currently lacks effective treatment. Fibroblast growth factor 21 (FGF21) has been shown to suppress nephropathy in both type 1 and type 2 diabetes mic...

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, Hua-Chun, Lu, Xin-Yu, Xu, Yu-Peng, Wang, Yi-Hong, Wang, Dan, Feng, Yi-Ling, Chi, Zhang, Yan, Xiao-Qing, Lu, Chao-Sheng, Wang, Hong-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590333/
https://www.ncbi.nlm.nih.gov/pubmed/34773993
http://dx.doi.org/10.1186/s10020-021-00408-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590333/
https://www.ncbi.nlm.nih.gov/pubmed/34773993
http://dx.doi.org/10.1186/s10020-021-00408-x

Ejemplares similares